The COVID Project
Context, not an orderThis record is guidance or an announcement kept for context. It is not counted among the orders in force.
The record
- Jurisdiction
- United States (federal); Drug Enforcement Administration, Diversion Control Division
- Level
- Federal
- Authority
- 21 U.S.C. 822(e); 21 C.F.R. 1301.12; DEA-DC-018 exception of Mar. 25, 2020
- Issued
- 2020-07-28 July 28, 2020
- Effective
- 2020-07-28
- End
- Restates the Mar. 25, 2020 exception, in force for the duration of the public health emergency
- In force
- July 28, 2020 (no end date recorded; counted as in force for 120 days)
- Quarters
- 2020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Telework mandateHealth care ordersOther
- Addressees
- DEA-registered practitioners prescribing by telemedicine
- Functions reached
- TM telehealth across State lines
- HR credentialing
- Character
- context
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
Question: I am registered with DEA in one state, but will be prescribing controlled substances to patients in another state via telemedicine in a manner permitted by the Ryan Haight Act. Will I need to hold a separate DEA registration in the state where my patients are located? Answer: Yes (with certain limited exceptions, including an exception broadly applicable during the COVID-19 public health emergency).
Enforcement
Registration requirements under 21 U.S.C. 822 and 842
Retrieval noteCite it as context and cite the underlying order, statute or emergency rule it describes as the instrument. (Bulletins whose operative text imposes a mandatory duty on licensees under the regulator's own authority are excluded from this downgrade and listed separately for review.)).